Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BDX

Baxter International Stock: Is BAX Underperforming the Health Care Sector?

Baxter International has lagged the broader health care sector by a wide margin over the past year, and analysts are taking a guarded stance on its outlook.

Barchart

Is Becton, Dickinson and Company Stock Underperforming the Nasdaq?

Becton, Dickinson and Company has notably underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Disney's new Olaf robot is so real, it'll give you chills

Disney Imagineering has already created a trove of animatronics and robots, maybe none more lovable than the Star Wars BDX Droids, but this next one is so real that it’s ice cool. Olaf, the walking, talking, and wisecracking snowman we all know from Frozen, is now a reality in the…

TechRadar

From analysis to the latest developments in health,
read the most diverse news in one place.

What Are Wall Street Analysts' Target Price for Becton, Dickinson and Company Stock?

Although Becton, Dickinson and Company has underperformed the broader market over the past year, Wall Street analysts maintain a measured optimism about the company’s long-term outlook.

Barchart

Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal

Becton Dickinson and Co (NYSE:BDX) reported fourth-quarter adjusted earnings of $3.96, beating the consensus of $3.92.

Benzinga

Here's What to Expect From Becton, Dickinson & Company’s Next Earnings Report

Becton, Dickinson & Company is gearing up to announce its Q4 results next month, with analysts calling for a slight dip in profits.

Barchart

BD CFO Set To Exit Company This December, Stock Falls

BD (Becton, Dickinson and Company) (NYSE:BDX) on Wednesday said Chris DelOrefice, executive vice president and chief financial officer (CFO), will depart the company effective December 5.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Is Becton, Dickinson and Company Stock Underperforming the S&P 500?

Despite Becton, Dickinson and Company’s underperformance relative to the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart

Is Intuitive Surgical Stock Underperforming the S&P 500?

Whereas Intuitive Surgical has delivered weaker returns than the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart

Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish?

Despite Becton, Dickinson and Company’s weak performance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Becton Dickinson Q3 Beats Estimates On Medical Device Boom

As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company (NYSE:BDX) are reporting robust financial performances that highlight their resilience and strategic adaptability. The company’s stock is trading higher on Thursday on better-than-expected third-quarter 2025 earnings.

Benzinga

Earnings Preview: What to Expect From Becton, Dickinson and Company's Report

Becton, Dickinson and Company will release its third-quarter earnings next month, and analysts anticipate a single-digit profit dip.

Barchart

Becton's Biosciences And Diagnostics Arm Slated To Join Waters In $17.5 Billion Merger

Becton, Dickinson and Company (NYSE:BDX) has agreed to combine its Biosciences Diagnostic Solutions business with Waters Corporation (NYSE:WAT).

Benzinga

How Is Becton, Dickinson and Company’s Performance Compared to Other Medical Instruments & Supplies Stocks?

Despite Becton, Dickinson and Company’s underperformance relative to its industry peers over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Becton, Dickinson and Company Stock: Analyst Estimates & Ratings

Despite Becton, Dickinson and Company’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Becton, Dickinson and Company’s Quarterly Earnings Preview: What You Need to Know

Becton, Dickinson and Company is set to announce its second-quarter results in the upcoming month, and analysts expect a single-digit growth in earnings.

Barchart

Becton, Dickinson, and Company Stock: Is BDX Underperforming the Healthcare Sector?

Becton, Dickinson and Company has lagged behind the broader healthcare sector recently, yet Wall Street analysts remain highly optimistic about its future growth potential.

TechRadar

The adorable BDX Droids are coming to more Disney Parks around the world, including Disney World

Disney Parks is bringing the adorable and impressive 'BDX Droids' to more parks worldwide, including Disney World. Plus, more details were unveiled for the update on the Smugglers Run attraction at Galaxy's Edge.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Medical Device Stocks Seeing Surge in Demand

From robotic surgery to smart diagnostics, the medical devices industry is transforming healthcare delivery. To capitalize on this trend, you might consider adding Boston Scientific Corp (BSX), Becton, Dickinson and Company (BDX), and The Cooper Companies (COO), which could boost your portfolio. Keep reading….

Barchart

Do Wall Street Analysts Like Becton, Dickinson and Company Stock?

MedTech giant Becton, Dickinson and Company underperformed relative to the broader market over the past year, but Wall Street analysts remain upbeat about the stock’s potential.

Barchart

Becton, Dickinson and Company's Q1 2025 Earnings: What to Expect

MedTech giant Becton, Dickinson and Company is expected to unveil its first-quarter results in the upcoming month and analysts expect a notable double-digit growth in earnings.

StockNews.com

3 Healthcare Innovators Advancing Medical Technology

The healthcare industry is set for growth due to evolving healthcare demands and the rapid evolution of medical technologies. Hence, investors might consider investing in healthcare stocks, Becton, Dickinson and Co. (BDX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC). Read more….

Barchart

Is Becton, Dickinson and Company Stock Underperforming the Dow?

Becton, Dickinson and Company have underperformed the Dow Jones Industrials Average over the past year, yet Wall Street analysts maintain a bullish outlook on the stock’s prospects.

StockNews.com

3 MedTech Innovators Revolutionizing Patient Care

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, investors could benefit from these trends by investing in fundamentally solid medical device stocks Becton, Dickinson and Company (BDX), Medtronic (MDT), and Abbott Laboratories (ABT), which are revolutionizing patient care. Keep reading.

Barchart

Becton, Dickinson and Company Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Becton, Dickinson and Company’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.